Custom Oligo Synthesis Market in China

Custom Oligo Synthesis in China Trends and Forecast

The future of the custom oligo synthesis market in China looks promising with opportunities in the biotech company and academic scientific research institution markets. The global custom oligo synthesis market is expected to grow with a CAGR of 7.2% from 2025 to 2031. The custom oligo synthesis market in China is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising demand for personalized medicine, the growing applications in diagnostics & therapeutics, and the increasing investments in research & development.

• Lucintel forecasts that, within the type category, modified primer synthesis is expected to witness higher growth over the forecast period.
• Within the application category, biotech company is expected to witness higher growth.

Emerging Trends in the Custom Oligo Synthesis Market in China

The custom oligo synthesis market in China is experiencing rapid growth driven by advancements in biotechnology, increasing demand for personalized medicine, and expanding research activities. Innovations in synthesis technology and rising investments in biotech startups are fueling market expansion. Additionally, government policies supporting biotech development and international collaborations are further accelerating this trend. These developments are transforming China into a key player in the global oligo synthesis industry, creating new opportunities and challenges for stakeholders.

• Technological Advancements: The integration of automation and high-throughput synthesis methods has significantly increased efficiency and accuracy in oligo production. This trend reduces costs and turnaround times, enabling faster research and development. It also allows for large-scale custom synthesis, meeting diverse client needs and fostering innovation in biotech applications.
• Growing Demand for Personalized Medicine: As precision medicine gains traction, there is a rising need for custom oligos tailored to individual genetic profiles. This trend is driving companies to develop specialized synthesis services, supporting targeted therapies and diagnostics. It enhances treatment efficacy and minimizes side effects, revolutionizing healthcare approaches in China.
• Expansion of Research and Development Activities: Increased investment in biotech research by both government and private sectors is boosting demand for custom oligos. Universities, research institutes, and biotech firms are collaborating to develop new applications, leading to a surge in orders. This growth supports innovation and positions China as a competitive player in global biotech research.
• Regulatory and Policy Support: Chinese government policies favor biotech innovation through funding, infrastructure development, and streamlined regulations. These supportive measures encourage local and international companies to expand their operations. They also ensure quality standards and intellectual property protections, fostering a sustainable growth environment for the oligo synthesis market.
• International Collaboration and Market Penetration: Chinese oligo synthesis companies are increasingly partnering with global firms to access new markets and technologies. These collaborations facilitate knowledge exchange and technology transfer, enhancing product quality and competitiveness. They also help Chinese firms establish a stronger presence in the global biotech ecosystem.

The emerging trends in the custom oligo synthesis market in China are reshaping the industry landscape by fostering innovation, improving efficiency, and expanding market reach. Technological advancements, increased demand for personalized medicine, supportive policies, and international collaborations are collectively driving growth. These developments position China as a significant global hub for oligo synthesis, creating new opportunities for stakeholders and setting the stage for sustained industry evolution.

Recent Developments in the Custom Oligo Synthesis Market in China

The custom oligo synthesis market in China is experiencing rapid growth driven by technological advancements, increasing pharmaceutical investments, and expanding biotech research. The rising demand for personalized medicine and genetic research fuels market expansion. Additionally, government initiatives supporting biotech innovation and the growing presence of international companies further accelerate development. This dynamic environment presents significant opportunities for market players to innovate and capture new customer segments, ultimately transforming China‘s biotech landscape and contributing to global advancements in genetic and molecular research.

• Growing Pharmaceutical and Biotech Investments: The surge in funding for biotech startups and research institutions in China is boosting demand for custom oligos, enabling more precise genetic analysis and drug development. This investment accelerates innovation, enhances research capabilities, and expands market reach, positioning China as a key player in global biotech advancements. The increased financial support also encourages local companies to develop advanced synthesis technologies, fostering competitive growth and market diversification.
• Technological Advancements in Oligo Synthesis: Innovations such as automation, high-throughput synthesis, and improved purity standards are enhancing efficiency and reducing costs. These technological improvements enable faster production cycles and higher quality products, meeting the increasing needs of research and clinical applications. As a result, companies can offer more customized solutions, attract a broader customer base, and strengthen their market position, ultimately driving market growth and innovation.
• Rising Demand for Personalized Medicine: The shift towards personalized treatment approaches in China is significantly increasing the need for custom oligos. These oligos are essential for gene editing, diagnostics, and targeted therapies. The growing prevalence of genetic disorders and cancer treatments fuels this demand, prompting companies to develop specialized oligo products. This trend not only expands market size but also encourages innovation in synthesis techniques tailored to specific medical applications.
• Government Policies Supporting Biotech Innovation: Chinese government initiatives, such as funding programs and regulatory reforms, are fostering a conducive environment for biotech growth. These policies promote research, facilitate market entry, and support the development of advanced synthesis technologies. The regulatory support encourages domestic and international companies to invest in the market, leading to increased competition, innovation, and overall market expansion.
• Expansion of International Collaborations and Market Presence: Chinese companies are forming strategic alliances with global biotech firms to access advanced technologies and expand their product portfolios. These collaborations facilitate knowledge exchange, improve synthesis quality, and open new markets. The increased international presence enhances China‘s competitiveness in the global oligo synthesis market, attracting foreign investment and fostering a more integrated and innovative industry landscape.

The overall impact of these developments is a robust, innovative, and competitive market environment in China. Increased investments, technological progress, and supportive policies are driving growth, expanding market size, and positioning China as a significant player in the global custom oligo synthesis industry. This evolution benefits research, healthcare, and biotech sectors, fostering advancements that will shape future medical and scientific breakthroughs.

Strategic Growth Opportunities in the Custom Oligo Synthesis Market in China

The custom oligo synthesis market in China is experiencing rapid expansion driven by increasing demand from biotech, pharmaceutical, and research sectors. Advances in synthetic biology, personalized medicine, and genomics are fueling growth opportunities. The market‘s evolution is also supported by technological innovations, government initiatives, and rising investments in life sciences. Companies are focusing on improving synthesis efficiency, reducing costs, and expanding application scopes to capture emerging opportunities and strengthen their market positions.

• Growing Demand for Personalized Medicine and Genomics Research: The rise in personalized treatments and genomic studies in China is significantly boosting the need for custom oligos. Researchers and pharmaceutical companies require high-quality, tailored oligonucleotides for diagnostics, gene editing, and therapeutic development. This trend is expected to continue as China invests heavily in biotech innovation, creating a substantial market for custom oligo synthesis services tailored to specific genetic sequences and research needs.
• Technological Advancements Enhancing Synthesis Efficiency and Accuracy: Innovations in synthesis technologies, such as automation, high-throughput methods, and improved chemistries, are enabling faster, more accurate, and cost-effective oligo production. These advancements allow manufacturers to meet the increasing quality standards demanded by biotech and pharmaceutical clients. As technology continues to evolve, companies that adopt cutting-edge synthesis platforms will gain competitive advantages, expanding their market share and enabling new applications in diagnostics and therapeutics.
• Rising Investments and Government Initiatives Supporting Biotech Growth: The Chinese government’s strategic initiatives, such as the "Made in China 2025" plan and biotech-specific funding programs, are fostering a conducive environment for market expansion. Increased investments in life sciences infrastructure, research grants, and innovation hubs are encouraging local companies to develop advanced oligo synthesis capabilities. This supportive ecosystem is attracting foreign players and stimulating domestic growth, ultimately broadening the market scope and accelerating industry development.
• Expansion of Applications in Diagnostics, Therapeutics, and Research: Custom oligos are increasingly used across diverse applications, including PCR, gene editing, antisense therapies, and molecular diagnostics. The expanding scope of these applications in China’s healthcare and research sectors is driving demand. As new therapeutic modalities and diagnostic tools emerge, the need for specialized oligos will grow, prompting companies to diversify their product offerings and develop application-specific solutions to meet evolving market needs.
• Increasing Focus on Quality Standards and Regulatory Compliance: As the market matures, there is a heightened emphasis on quality assurance, regulatory compliance, and certification standards. Companies investing in quality management systems and adhering to international guidelines will gain trust and expand their customer base. This focus on quality not only ensures product reliability but also opens opportunities for market entry into regulated sectors such as clinical diagnostics and therapeutics, further fueling market growth.

The overall impact of these opportunities is a robust, innovative, and competitive market landscape in China’s custom oligo synthesis industry. By leveraging technological advancements, government support, and expanding applications, the market is poised for sustained growth. Companies that focus on quality, efficiency, and diversification will be well-positioned to capitalize on emerging trends, ultimately strengthening China’s role as a key player in the global oligo synthesis market.

Custom Oligo Synthesis Market in China Driver and Challenges

The custom oligo synthesis market in China is shaped by a complex interplay of technological advancements, economic growth, and evolving regulatory frameworks. Rapid innovation in biotechnology and molecular research fuels demand for customized oligonucleotides, while China‘s expanding pharmaceutical and biotech sectors provide a fertile market environment. However, regulatory challenges related to quality standards and intellectual property rights pose hurdles. Additionally, economic factors such as investment in R&D and government initiatives significantly influence market dynamics. Understanding these drivers and challenges is essential for stakeholders aiming to capitalize on opportunities within this rapidly evolving landscape.

The factors responsible for driving the custom oligo synthesis market in China include:-
• Technological Innovation: The continuous development of advanced synthesis techniques, automation, and high-throughput methods enhances efficiency and accuracy, reducing costs and turnaround times. This technological progress enables companies to meet increasing demand from research institutions, pharmaceutical companies, and biotech firms. As China invests heavily in biotech R&D, the adoption of cutting-edge synthesis technologies accelerates market growth, fostering innovation and expanding application areas such as gene editing, diagnostics, and therapeutics.
• Growing Biotech and Pharmaceutical Sectors: China‘s expanding biotech and pharmaceutical industries are major drivers, driven by government policies supporting innovation and healthcare reforms. The rising prevalence of chronic diseases and the need for personalized medicine increase demand for custom oligos for research, diagnostics, and drug development. This sector growth creates a robust market for oligo synthesis services, encouraging local and international companies to establish manufacturing and R&D facilities within China.
• Increasing Research and Development Activities: China’s focus on scientific research, supported by government funding and academic collaborations, boosts demand for custom oligos. Universities and research institutes require high-quality oligonucleotides for genomics, proteomics, and molecular biology studies. The surge in R&D activities, especially in genomics and personalized medicine, propels the need for reliable synthesis services, fostering market expansion and technological innovation.
• Rising Investment and Government Initiatives: The Chinese government’s strategic initiatives, such as the "Made in China 2025" plan and biotech-specific policies, promote innovation and infrastructure development. Increased funding for biotech startups and research projects encourages the adoption of custom oligo synthesis. These initiatives facilitate market entry, support technological advancements, and enhance manufacturing capabilities, thereby driving overall market growth.
• Increasing Adoption of Precision Medicine: The shift towards personalized healthcare solutions in China is a significant driver. Custom oligos are essential for gene therapy, diagnostics, and targeted treatments. As awareness and acceptance of precision medicine grow, demand for tailored oligonucleotides rises. This trend encourages companies to develop specialized synthesis services, expanding the market and fostering innovation in therapeutic applications.

The challenges in the custom oligo synthesis market in China are:-
• Regulatory and Quality Standards: Stringent regulatory frameworks and quality control requirements pose significant challenges. Ensuring compliance with international standards such as ISO and GMP is complex and costly, especially for smaller players. Variability in quality standards across regions can hinder market entry and expansion, while delays in approval processes impact product launches and R&D timelines, ultimately affecting competitiveness and trust in the market.
• Intellectual Property Concerns: The risk of intellectual property infringement and patent issues remains a concern for companies operating in China. Protecting proprietary synthesis technologies and sequences is challenging due to weak enforcement of IP rights, which discourages innovation and investment. This environment can lead to counterfeit products and reduced confidence among international players, impacting market growth and technological advancement.
• Supply Chain and Raw Material Dependence: Dependence on imported raw materials and reagents creates vulnerabilities in the supply chain. Fluctuations in global trade policies, tariffs, and logistics disruptions can lead to delays and increased costs. Ensuring a stable supply of high-quality raw materials is critical for maintaining product quality and meeting market demand, but current dependencies hinder scalability and operational efficiency.

In summary, the custom oligo synthesis market in China is driven by technological innovation, sector growth, R&D activities, government support, and the adoption of precision medicine. However, regulatory complexities, IP concerns, and supply chain vulnerabilities present notable challenges. These factors collectively influence market dynamics, requiring stakeholders to navigate a landscape of rapid growth amid regulatory and operational hurdles. Overall, the market‘s future hinges on balancing innovation with regulatory compliance and supply chain resilience, promising substantial growth opportunities in China‘s expanding biotech ecosystem.

List of Custom Oligo Synthesis Market in China Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, custom oligo synthesis companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the custom oligo synthesis companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10

Custom Oligo Synthesis Market in China by Segment

The study includes a forecast for the custom oligo synthesis market in China by type and application.

Custom Oligo Synthesis Market in China by Type [Value from 2019 to 2031]:

• Common Primer Synthesis
• Modified Primer Synthesis

Custom Oligo Synthesis Market in China by Application [Value from 2019 to 2031]:

• Biotech Company
• Academic Scientific Research Institution
• Others

Features of the Custom Oligo Synthesis Market in China

Market Size Estimates: Custom oligo synthesis in China market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Custom oligo synthesis in China market size by type and application in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different type and application for the custom oligo synthesis in China.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the custom oligo synthesis in China.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What are the major drivers influencing the growth of the custom oligo synthesis market in China?
Answer: The major drivers for this market are the rising demand for personalized medicine, the growing applications in diagnostics & therapeutics, and the increasing investments in research & development.
Q2. What are the major segments for custom oligo synthesis market in China?
Answer: The future of the custom oligo synthesis market in China looks promising with opportunities in the biotech company and academic scientific research institution markets.
Q3. Which custom oligo synthesis market segment in China will be the largest in future?
Answer: Lucintel forecasts that, within the type category, modified primer synthesis is expected to witness higher growth over the forecast period.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 10 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the custom oligo synthesis market in China by type (common primer synthesis and modified primer synthesis), and application (biotech company, academic scientific research institution, and others)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Custom Oligo Synthesis Market in China, Custom Oligo Synthesis Market in China Size, Custom Oligo Synthesis Market in China Growth, Custom Oligo Synthesis Market in China Analysis, Custom Oligo Synthesis Market in China Report, Custom Oligo Synthesis Market in China Share, Custom Oligo Synthesis Market in China Trends, Custom Oligo Synthesis Market in China Forecast, Custom Oligo Synthesis Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.